ArticleInternational journal of clinical oncology2025

Evaluating the impact of atezolizumab on febrile neutropenia occurrence in patients with NSCLC undergoing chemotherapy in Japan: a real-world post-marketing database study.

Sayuri Nakane et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.